News

Coats highlighted early patient education, simulation strategies, and optometry–ophthalmology collaboration during a session on toric lenses.

The National Eye Institute Visual Function Questionnaire was a tool that has been used previously to assess the patient-reported vision-related quality of life in patients with floaters.

New interim data demonstrate that more than half of children wearing DOT lenses experienced no clinically meaningful myopia progression over 18 months.

Eye care providers are uniquely positioned to catch early risks during routine exams.

Catch up on the top stories in optometry during the week of September 29-October 3.

The latest in drug and technology developments and updates from September 2025.

Jeffrey Walline, OD, PhD, said that the growing amount of CE sessions available is what sets the annual Academy meeting apart from other conferences.

Smith highlights advances in interventional glaucoma, including first-line SLT, emerging surgical options, and comanagement strategies, during the Ophthalmology Times and Optometry Times EyeCon 2025 conference.

Thomas A. Albini, MD; Rahul Tonk, MD, MBA; Alison Bozung, OD, FAAO; and Joseph Allen, OD, FAAO, Dipl ABO, weigh in on what they gained from the conference.

Mark Bullimore, PhD, MCOptom, FAAO, like other ODs, is anxiously awaiting further clinical trial results.

Keeping an eye on CE, industry news, and collaboration in Boston, Massachusetts.

Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, will be joined by a handful of colleagues to discuss the latest in retina in Boston, Massachusetts, from October 8 to 11.

Commercial product shipments will be initiated for patients in October through LENZ’s ePharmacy partner, and the product is anticipated to be available in commercial locations such as retail pharmacies by the middle of the fourth quarter of this year.

Transforming care by integrating systemic, ocular, and emotional health can deliver personalized treatment and better outcomes.

The researchers noted the importance of comprehensive eye examinations, including cycloplegic refraction for diagnosing and managing common pediatric ocular conditions, especially in children who fail vision screening.

Theis outlined her “rule of 3” for evaluating urgent neuro-ophthalmic cases and discussed how retinal findings can reveal early neurodegenerative changes.

Thomas Albini, MD, shares his insights about common cases and the triaging process for patients with ocular trauma.

Catch up on the top stories in optometry during the week of September 22-September 26.

Three residents were honored in the categories of Best in Ophthalmology, Best in Optometry, and Best in Retina Care during a ceremony at EyeCon 2025.

Mark Bullimore, MCOptom, PhD, FAAO, gave a presentation on myopia management alongside Vishakha Thakrar, OD, FAAO, FSLS, at the conference.

Rahul Tonk, MD, MBA, outlines a session he gave alongside Joseph Allen, OD, FAAO, Dipl ABO, at EyeCon 2025.

Allen discussed therapies such as perfluorohexyloctane and amniotic membrane use, stressing the importance of timely treatment and coordinated patient management.

The lens works to slow the progression of myopia in children aged 6 to 12 years at the initiation of treatment.

The “chip-on-eye” platform works by mimicking the flow of ocular fluids through the endothelial wall.

Study participants were followed annually from 2006 to 2018 with cycloplegic refractions and ocular biometry; the parents were followed with noncycloplegic refractions and ocular biometry.

Diana Canto-Sims, OD, did the digging on private label eyewear companies so you don't have to.

The Delaying the Onset of Nearsightedness Until Treatment (DONUT) study will be the first of its kind in the US.